SEC Form 4 · accession 0001235802-17-000034
ENTELLUS MEDICAL INC · ENTL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martha J. Christian
Officer — Vice President, Reimbursement
Period of report
Mar 4, 2017
Accepted (ET)
Mar 7, 2017 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374128
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Statutory Stock Option (right to buy)F1 | $13.45 | Mar 4, 2017 | A | 30,000 | A | — | Mar 4, 2027 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1This option vests with respect to 25% of the shares on February 27, 2018 and with respect to 1/48th of the shares on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with Entellus Medical, Inc.